In lab samples of pancreas and salivary gland, a compound called D-mannoheptulose strongly blocks the first step of sugar processing.
See the scientific wording
In isolated pancreatic islet homogenates and isolated parotid cell homogenates, D-mannoheptulose inhibits hexose phosphorylation, the first step of glucose metabolism, and the claim describes this inhibition as efficient; no dose, duration, or quantitative effect size (absolute or relative) is reported.
Mixed evidence
Observational2 of 3 parts have evidence behind them.
Mixed evidence
2 of 3 parts have evidence behind them.
Parts of this claim
D-mannoheptulose efficiently inhibits hexose phosphorylation in isolated pancreatic islet homogenates.
Supported1 studyD-mannoheptulose efficiently inhibits hexose phosphorylation in parotid cell homogenates.
Supported1 studyHexose phosphorylation is the first step of glucose metabolism.
Not testedNo studies
Evidence is judged against each part on its own, so a study that tests one part never counts as a verdict on the whole claim.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyIn vitro1998
The abstract explicitly states that D-mannoheptulose caused efficient inhibition of hexose phosphorylation in both parotid cell and islet homogenates. This direct measurement in homogenates supports the claim that the compound blocks this early step of glucose metabolism.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
D-mannoheptulose is a sugar-like molecule that resembles glucose. In broken-open cells from the pancreas and salivary glands, it competes with glucose for the enzyme hexokinase/glucokinase. This blocks the enzyme from adding a phosphate group to glucose, so glucose cannot become glucose-6-phosphate, the first step of sugar breakdown. In pancreatic islets, this block also stops the signals that lead to insulin release. In whole salivary gland cells, the molecule cannot reach the enzyme well, so the block does not happen there, but in broken-open cells the block is strong.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In lab samples of pancreas and salivary gland, a compound called D-mannoheptulose strongly blocks the first step of sugar processing.
Mechanism
1 studyThe molecule D-mannoheptulose looks like glucose and blocks the enzyme that normally puts a phosphate tag on glucose. In broken-open pancreas and salivary gland cells, the enzyme is easy to reach, so the block is strong and sugar processing stops at the first step. In whole salivary gland cells, the molecule cannot get to the enzyme well, so the block does not affect sugar breakdown there, but the claim is about broken-open cells where the block works.
D-mannoheptulose is a sugar-like molecule that resembles glucose. In broken-open cells from the pancreas and salivary glands, it competes with glucose for the enzyme hexokinase/glucokinase. This blocks the enzyme from adding a phosphate group to glucose, so glucose cannot become glucose-6-phosphate, the first step of sugar breakdown. In pancreatic islets, this block also stops the signals that lead to insulin release. In whole salivary gland cells, the molecule cannot reach the enzyme well, so the block does not happen there, but in broken-open cells the block is strong.
D-mannoheptulose, a seven-carbon sugar that resembles D-glucose, competes with D-glucose for binding to hexokinase and glucokinase in pancreatic islet and parotid cell homogenates.
This competitive binding prevents the enzyme from transferring a phosphate group from ATP to D-glucose, blocking the formation of glucose-6-phosphate.
Because glucose-6-phosphate is the first intermediate of glucose metabolism, its reduced production lowers flux through glycolysis and oxidative metabolism. In pancreatic islets, this decrease in glucose metabolism reduces the metabolic signals that trigger insulin release.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of In Vitro Studies on D-Mannoheptulose Inhibition of Hexose Phosphorylation in Pancreatic Islet and Parotid Homogenates
Systematic search and meta-analysis of controlled in vitro studies using isolated pancreatic islet and parotid cell homogenates, comparing D-mannoheptulose vs vehicle/no inhibitor, with hexose phosphorylation rate as the outcome.
Controlled In Vitro Assay of D-Mannoheptulose on Hexose Phosphorylation in Pancreatic Islet and Parotid Homogenates
Prepare isolated pancreatic islet and parotid cell homogenates, incubate with D-mannoheptulose at multiple concentrations vs vehicle control, measure hexose phosphorylation (e.g., radiolabeled glucose or enzymatic assay), and determine IC50 and maximum inhibition.
Expert Consensus Review on D-Mannoheptulose as a Hexose Phosphorylation Inhibitor
Narrative review by biochemists summarizing and critically appraising in vitro evidence on D-mannoheptulose and hexose phosphorylation.